Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine, Cytarabine, and Thymoglobulin Conditioning for MDS and AML
NCT00593645Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2007
- Primary completion
- Dec 2008
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine, cytarabine, antithymocyte globulin in myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), sponsored by Washington University School of Medicine. Started Nov 2007; status: terminated.
02
Drugs
clofarabinecytarabineantithymocyte globulin
03
Conditions
myelodysplastic syndrome (MDS)acute myeloid leukemia (AML)chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on NCT00593645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593645.